Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
- Conditions
- Meibomian Gland DysfunctionDry Eye
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- TearScience, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02102464
- Locations
- 🇺🇸
School of Optometry, The University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Clayton Eye Center, Morrow, Georgia, United States
🇺🇸Charlotte Eye Ear Nose and Throat Associates, P.A., Charlotte, North Carolina, United States
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
- Conditions
- BlepharitisDry Eye Syndrome
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- TearScience, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT01808560
- Locations
- 🇺🇸
Chicago Cornea Consultants, Ltd., Hoffman Estates, Illinois, United States
🇺🇸Jackson Eye, Lake Villa, Illinois, United States
🇺🇸Charles River Eye Associates, Winchester, Massachusetts, United States
Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye
- Conditions
- Dry EyeMeibomian Gland Dysfunction
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- TearScience, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT01521507
- Locations
- 🇺🇸
McDonald Eye Associates, Fayetteville, Arkansas, United States
🇺🇸Harvard Eye Associates, Laguna Hills, California, United States
🇺🇸Center for Excellence in Eye Care, Miami, Florida, United States
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
- Conditions
- ChalazionDry Eye Syndromes
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- TearScience, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01202747
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
- Conditions
- ChalazionDry Eye Syndromes
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2011-12-12
- Lead Sponsor
- TearScience, Inc.
- Target Recruit Count
- 139
- Registration Number
- NCT00832130
- Prev
- 1
- 2
- Next